![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Printz Carrie
Publisher: Blackwell Publishing
E-ISSN: 1097-0142|121|20|3563-3563
ISSN: 0008-543X
Source: Cancer, Vol.121, Iss.20, 2015-10, pp. : 3563-3563
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anthracycline benefits vastly restricted in breast cancer
Inpharma, Vol. 1, Iss. 1620, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trastuzumab without an anthracycline: better for early breast cancer
Inpharma, Vol. 1, Iss. 1574, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Hurria Arti Hurria Anju Brogan Kelly Panageas Katherine S. Pearce Carol Norton Larry Jakubowski Ann Howard Jane Hudis Clifford
Drugs & Aging, Vol. 22, Iss. 9, 2005-01 ,pp. :